Rheumacare capsules recall — Class I (D-0332-2026) · pharmaranks
Class IOngoing
Rheumacare capsules recall
FDA recall D-0332-2026 · initiated Dec 22, 2025
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
CGMP Deviations: product found to contain lead.
Details
Product
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
Recalling company
HANDELNINE GLOBAL LLC
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Product was distributed to one customer in NY.
Initiated
Dec 22, 2025
FDA report date
Feb 11, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.